arrow
R

Robert A. Jolly

lilly research laboratories
H指数:26
被引数:2,515

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Applicability of the ICH M7 Guidelines for Assessing Less-than-Lifetime Exposure to Nitrosamine Impurities in Drug Products

ICH M7指导原则在评估药物产品中亚硝胺杂质低于一生暴露情况下的适用性

2026-09-110
OAAI
Ames Concordance with the In Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response Carcinogenicity Data
2026-01-300
PRE
Assessment and Control of Host Cell Proteins in Biologics: Survey of Industry Practices and a Vision for Harmonization

生物制剂中宿主细胞蛋白的评估和控制: 行业实践调查和协调愿景

2026-01-010
PRE
HESI GTTC ring trial: Concordance between Ames and rodent carcinogenicity outcomes for N-nitrosamines (NAs) with rat and hamster metabolic conditions

HESI GTTC环试:在N-亚硝胺(NAs)的Ames试验与啮齿类动物致癌性结果之间,大鼠和仓鼠代谢条件下的符合性研究

2025-06-110
OAAI
N-Nitrosamine drug substance related impurities (NDSRIs) - A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight > 200 Da

N-亚硝胺原料药相关杂质 (NDSRIs) -关于分子量> 200 Da的NDSRIs在致癌性效力分类方法类别1和2中增加子类别的建议

2024-12-012
PRE
Principles and procedures for assessment of acute toxicity incorporating in silico methods
2022-11-018
OAAI
Skin sensitization in silico protocol

silico协议中的皮肤致敏

2020-10-0131
OAAI
Genetic toxicology in silico protocol

计算机协议中的遗传毒理学

2019-10-0149
OAAI
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analyses
2019-03-0122
OAAI
In silico toxicology protocols

计算机毒理学协议

2018-07-01153
OAAI
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity
2016-06-0138
PREAI
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses
2016-06-0182
OAAI